Clinical Trials Logo

Abortion, Second Trimester clinical trials

View clinical trials related to Abortion, Second Trimester.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05322252 Recruiting - Clinical trials for Pregnancy Complications

Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial

MIST
Start date: July 1, 2022
Phase: Phase 4
Study type: Interventional

When time allows, administration of mifepristone prior to second trimester induction of labor decreases total labor time. However, in the setting of many pregnancy complications, decreasing time from diagnosis of nonviable pregnancy to delivery is of utmost importance to decrease risk of maternal complications. Previous data has shown that total abortion time is longer in the group receiving mifepristone owing to the delay between mifepristone administration and initiation of misoprostol induction of labor. Thus, the investigators aim to investigate whether simultaneous mifepristone and misoprostol has benefits over misoprostol alone when labor induction of a nonviable second trimester cannot be delayed.

NCT ID: NCT03106389 Recruiting - Misoprostol Clinical Trials

Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy

Start date: March 1, 2017
Phase: Phase 4
Study type: Interventional

This randomized controlled study will be performed to compare the benefits and risks associated with the administration of misoprostol with or without the use of a transcervical balloon catheter to terminate pregnancy in the second trimester (defined as gestational age between 14 and 28 weeks of gestation).